On September 26, 2017, the Food and Drug Administration (FDA) published a final guidance document providing further clarity on how FDA classifies a product as a drug, device, biological product, or a combination product, entitled “Classification of Products as Drugs and Devices & Additional Product Classification Issues” (Final Guidance). See 82 FR 44802 (Sept. 26, 2017).
Please see full publication below for more information.